CSIMarket



Sangui Biotech International Inc  (SGBI)
Other Ticker:  
 

Cumulative Sangui Biotech International Inc's Working Capital Ratio for Trailing Twelve Months Period

SGBI's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

SGBI Working Capital Ratio for Trailing Twelve Months Period

(Mar 31 2022)
III. Quarter
(Dec 31 2021)
II. Quarter
(Sep 30 2021)
I. Quarter
(Jun 30 2021)
IV. Quarter
(Mar 31 2021)
III. Quarter
Y / Y Current Liabilities Growth 2.5 % 4.63 % 8.58 % 20.62 % 31.16 %
Y / Y Current Assets Growth 110.36 % 37.29 % -25.39 % 36.9 % 3.2 %
Working Capital Ratio for Trailing Twelve Months Period 0.07 0.06 0.06 0.06 0.06
Total Ranking # 5355 # 5703 # 4582 # 4695 # 4628
Seq. Current Liabilities Growth -0.8 % 1.62 % 1.41 % 0.26 % 1.25 %
Seq. Current Assets Growth 105.78 % 13.32 % -26.16 % 22.17 % 34.3 %


Working Capital Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Sangui Biotech International Inc Current Assets average more than doubled by 110.36 % in III. Quarter year on year, faster than Current Liabilities, this led to increase in in Sangui Biotech International Inc's Working Capital Ratio for Trailing Twelve Months Period to 0.07, Working Capital Ratio for Trailing Twelve Months Period remained below Sangui Biotech International Inc average.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 253 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Sangui Biotech International Inc. While Working Capital Ratio for Trailing Twelve Months Period overall ranking has improved so far to 5355, from total ranking in previous quarter at 5703.

What is Working Capital Ratio?
More about SGBI
Working Capital Ratio SGBI in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 254
Sector # 1063
S&P 500 # 5321


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.4 0.18 0.06
(Sep. 30, 2015)   (Sep 30 2021)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Mar 31 2022, within Biotechnology & Pharmaceuticals Industry Working Capital Ratio for Trailing Twelve Months Period
Ainos Inc   0.15 
Gtx Corp  0.15 
Cannabis Global Inc.  0.14 
Organicell Regenerative Medicine Inc.  0.13 
Cell Medx Corp   0.12 
Immune Therapeutics Inc   0.09 
Q Biomed inc.  0.09 
Cardax Inc   0.09 
Sangui Biotech International Inc  0.08 
Quest Patent Research Corp  0.06 
Qrons Inc.  0.04 
Alpha Network Alliance Ventures Inc   0.02 
Cannapharmarx Inc.  0.02 
Skinvisible Inc   0.02 
Regen Biopharma Inc.  0.02 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TWO's Profile

Stock Price

TWO's Financials

Business Description

Fundamentals

Charts & Quotes

TWO's News

Suppliers

TWO's Competitors

Customers & Markets

Economic Indicators

TWO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071